Market Overview

The Global Psoriatic Arthritis Therapeutics Market was valued at USD 10,633.4 million in 2023 and is expected to reach USD 28,068.7 million by 2031 while growing at a CAGR of 12.9% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global psoriatic arthritis therapeutics market growth. Psoriatic arthritis (PsA) therapeutics encompass the array of treatment options for addressing this chronic inflammatory joint condition, which often accompanies psoriasis, a skin disorder marked by red, scaly patches. Psoriatic arthritis manifests in the joints, skin, nails, and other body parts. The treatment strategies aim to diminish inflammation, alleviate symptoms, forestall joint damage, and enhance overall quality of life.

The increasing prevalence of psoriatic arthritis, combined with ongoing research and development efforts resulting in the discovery of new pharmacological agents, biologics, and targeted therapies, propels the psoriatic arthritis (PsA) therapeutics market. Nevertheless, obstacles such as the high cost of treatment and concerns regarding safety and tolerability hinder the growth of the market.

Furthermore, the global psoriatic arthritis therapeutics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Drug Class Analysis

The Global Psoriatic Arthritis Therapeutics Market is segmented among Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease-modifying Antirheumatic Drugs (DMARDs), Biologics, and Others, based on Drug Class. In 2023, Non-steroidal Anti-inflammatory Drugs (NSAIDs) accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Product Type Analysis

The Global Psoriatic Arthritis Therapeutics Market is segmented among Prescription, and Over the counter, based on Product Type. In 2023, Prescription accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Psoriatic Arthritis Therapeutics Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Aerotel Medical Systems Ltd, AliveCor Inc., BPL Medical Technologies, Bittium, CardioComm Solutions Inc., GE Healthcare, iRhythm Technologies Inc., MediBioSense Ltd, Medtronic PLC, and Nihon Kohden Corporation.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Psoriatic Arthritis Therapeutics Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Psoriatic Arthritis Therapeutics Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Psoriatic Arthritis Therapeutics Market Segmentation, By Drug Class

• Global Psoriatic Arthritis Therapeutics Market Share Analysis, By Drug Class

• Global Psoriatic Arthritis Therapeutics Market Growth Analysis, By Drug Class

• Global Psoriatic Arthritis Therapeutics Market Trends, By Drug Class

o Non-steroidal Anti-inflammatory Drugs (NSAIDs)

o Disease-modifying Antirheumatic Drugs (DMARDs)

o Biologics

o Others

6. Global Psoriatic Arthritis Therapeutics Market Segmentation, By Product Type

• Global Psoriatic Arthritis Therapeutics Market Share Analysis, By Product Type

• Global Psoriatic Arthritis Therapeutics Market Growth Analysis, By Product Type

• Global Psoriatic Arthritis Therapeutics Market Trends, By Product Type

o Prescription

o Over the counter  

7. Global Psoriatic Arthritis Therapeutics Market Segmentation, By Distribution Channel

• Global Psoriatic Arthritis Therapeutics Market Share Analysis, By Distribution Channel

• Global Psoriatic Arthritis Therapeutics Market Growth Analysis, By Distribution Channel

• Global Psoriatic Arthritis Therapeutics Market Trends, By Distribution Channel

o Hospital Pharmacies

o Retail Pharmacies

o Online Pharmacies

8. Global Psoriatic Arthritis Therapeutics Market Segmentation, By Region

• Global Psoriatic Arthritis Therapeutics Market Share Analysis, By Region

• Global Psoriatic Arthritis Therapeutics Market Growth Analysis, By Region

• Global Psoriatic Arthritis Therapeutics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

• Aerotel Medical Systems Ltd*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• AliveCor Inc.

• BPL Medical Technologies

• Bittium

• CardioComm Solutions Inc.

• GE Healthcare

• iRhythm Technologies Inc.

• MediBioSense Ltd

• Medtronic PLC

• Nihon Kohden Corporation

*Similar analysis will be provided for each company listed above.